Libtayo plus chemotherapy is potentially more cost-effective than Keytruda plus chemotherapy for advanced NSCLC, offering lower costs and higher QALYs. The study's model, based on clinical trial data, ...
Jazz Pharmaceuticals and Zymeworks announced positive topline phase 3 results for Ziihera in HER2-positive GEA. Click here to ...
The Hearty Soul on MSN
Woman with Stage 4 Cancer Refuses Chemotherapy in Favor of 21-Day Water Fast: ‘People Will Judge, But I Believe It's Right for Me'
A cancer diagnosis forces us to make decisions that we never imagined ourselves making. This is especially when the regular ...
OKLAHOMA CITY (KFOR) — Oklahoma City Thunder guard Nikola Topić has been diagnosed with testicular cancer, according to general manager Sam Presti. Presti said Topić, 20, began chemotherapy after the ...
Thunder's Nikola Topić receiving chemotherapy treatment after being diagnosed with testicular cancer
Oklahoma City Thunder guard Nikola Topić has been diagnosed with testicular cancer and is receiving chemotherapy treatment, according to Thunder general manager Sam Presti. Presti told reporters ...
Oklahoma City Thunder guard Nikola Topic has been diagnosed with testicular cancer and is undergoing chemotherapy. Sam Presti, the team’s general manager, announced the diagnosis on Thursday. Topic ...
Topic had a testicular procedure earlier in the month. The Thunder said at the time he'd be out for at least four weeks. Presti said doctors are “extremely positive” about his long-term outlook. He ...
Graduate from high school. Get a job. Don't have kids until you're married. Called the "success sequence," Ohio lawmakers want public schools to teach students that these basic rules will improve ...
BERLIN -- The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly improved overall survival (OS) among previously treated patients with metastatic ...
In recent research, treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in ...
On October 12, 2025, much-deserved success arrives for three zodiac signs. The Waning Gibbous Moon in Cancer is terrific when it comes to reminding us to stay persistent. We're looking at a day that ...
A research team at CiQUS (University of Santiago de Compostela, Spain) has unveiled an innovative molecular approach that enables anticancer drugs to reach the nucleus of tumor cells, where they can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback